Koca, Ö. A. Et Al. 2024. Formulation and Characterization Studies of Paclitaxel Incorporated Kollidon® SR and Chitosan Nanoparticles: An In vitro Evaluation for Potential Use for Colorectal Cancer Treatment. LETTERS IN DRUG DESIGN & DISCOVERY , vol.21, no.1 , 189-202.

Koca, Ö. A., Büyükköroğlu, G., & Başaran, E., (2024). Formulation and Characterization Studies of Paclitaxel Incorporated Kollidon® SR and Chitosan Nanoparticles: An In vitro Evaluation for Potential Use for Colorectal Cancer Treatment. LETTERS IN DRUG DESIGN & DISCOVERY , vol.21, no.1, 189-202.

Koca, Özge, GÜLAY BÜYÜKKÖROĞLU, And EBRU BAŞARAN. "Formulation and Characterization Studies of Paclitaxel Incorporated Kollidon® SR and Chitosan Nanoparticles: An In vitro Evaluation for Potential Use for Colorectal Cancer Treatment," LETTERS IN DRUG DESIGN & DISCOVERY , vol.21, no.1, 189-202, 2024

Koca, Özge A. Et Al. "Formulation and Characterization Studies of Paclitaxel Incorporated Kollidon® SR and Chitosan Nanoparticles: An In vitro Evaluation for Potential Use for Colorectal Cancer Treatment." LETTERS IN DRUG DESIGN & DISCOVERY , vol.21, no.1, pp.189-202, 2024

Koca, Ö. A. Büyükköroğlu, G. And Başaran, E. (2024) . "Formulation and Characterization Studies of Paclitaxel Incorporated Kollidon® SR and Chitosan Nanoparticles: An In vitro Evaluation for Potential Use for Colorectal Cancer Treatment." LETTERS IN DRUG DESIGN & DISCOVERY , vol.21, no.1, pp.189-202.

@article{article, author={Özge Atasoy Koca Et Al. }, title={Formulation and Characterization Studies of Paclitaxel Incorporated Kollidon® SR and Chitosan Nanoparticles: An In vitro Evaluation for Potential Use for Colorectal Cancer Treatment}, journal={LETTERS IN DRUG DESIGN & DISCOVERY}, year=2024, pages={189-202} }